Multiple Sclerosis Research Biomarkers

What is the Purpose of this Study?

The purpose of this study is to determine whether combining information from visual assessment and blood markers, as well as historical and ongoing magnetic resonance imaging (MRI) of the brain, orbit (the part of the skull where eyes are located), or spinal cord can predict disability progression due to neurological disease. Researchers hope to learn whether several biomarkers (MRI scan, blood tests, or visual assessment) can correlate with long-term disability and clinical outcomes in multiple sclerosis and related disorders (MSRD) and their response to therapy. Biomarkers may be a sign of a condition or disease and can be used to predict an individual's response to a specific treatment or risk of disability in the future.


Eligibility

Not Available


Where can I participate?

Beverly


What is the full name of this clinical trial?

Investigating the longitudinal relationships between visual pathway injury, radiological and blood biomarkers in multiple sclerosis and related disorders

Study Details
Disease Type/Condition

Multiple Sclerosis

Principal Investigator

Al-Louzi, Omar

Age Group

Adult

Phase

Not Available

IRB Number

STUDY00001690


How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Multiple Sclerosis

Principal Investigator

Al-Louzi, Omar

Age Group

Adult

Phase

Not Available

IRB Number

MS-REBS


Contact
Email
clinicaltrials@cshs.org